Macralp(A) Enzyme Immunoassay Kit

FDA 510(k) K971157 · Strategic Diagnostics, Inc.

Substantially Equivalent

510(k) numberK971157

Submission

Device name
Macralp(A) Enzyme Immunoassay Kit
Applicant
Strategic Diagnostics, Inc.
Newark, DE, US
Received
March 28, 1997
Decision date
April 15, 1998
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) statement available from FDA

Official FDA 510(k) record

Device classification

Product code
JHO – Electrophoretic Separation, Lipoproteins
Device class
Class I (low risk)
Regulation
21 CFR 862.1475
Specialty
Clinical Chemistry

Other 510(k)s with product code JHO

510(k)DeviceApplicantDecision
K022333Spife LIPPOROTEIN-12, Model 3344JHO · Traditional Helena Laboratories08/15/2002SE
K022053Hydragel 7 Lipoprotein(E), PN 4114 & Hydragel Lipoprotein(E) 15/30 PN 4134JHO · Special Sebia07/12/2002SE
K013662Modification to Lipoprint System, LDL SubfractionsJHO · Special Quantimetrix Corp.03/08/2002SE
K012789Modified to Ldl/Hdl Chol Direct Kit-P.N. 4005, 4103,4123JHO · Special Morax01/17/2002SE
K013466Spife 2000/3000 Lipoprotein; Model# 3340, 3341, 3342, 3343JHO · Traditional Helena Laboratories12/21/2001SE
K010337Lipoprint System, LDL SubfractionsJHO · Traditional Quantimetrix Corp.07/25/2001SE
K000603Spife Cholesterol Profile KitJHO · Traditional Helena Laboratories04/17/2000SE
K992971Rep Cholesterol Profile KitJHO · Traditional Helena Laboratories10/18/1999SE
K974854Hydragel-Mini Lipo Kit-Pn 4093, Hydragel Lipo Kit-Pn 4007, Hydragel Lipo Maxi Kit-Pn 4207JHO · Traditional Morax10/07/1998SE
K980650Rep Cholesterol Profile TEMPLATE-30, -16, -8; Rep Vis CholesterolJHO · Traditional Helena Laboratories05/01/1998SE

Questions and answers

When was Macralp(A) Enzyme Immunoassay Kit cleared by the FDA?

Macralp(A) Enzyme Immunoassay Kit (K971157) received a 510(k) decision of Substantially Equivalent on April 15, 1998, 383 days after the submission was received.

What is the product code of K971157?

The FDA product code is JHO – Electrophoretic Separation, Lipoproteins, a Class I (low risk) device regulated under 21 CFR 862.1475.